Perbedaan Diagnos Laboratorium Utama Tbk. dan Saraswanti Indoland Development Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Saraswanti Indoland Development Tbk. diperdagangkan di Rp93 (kapitalisasi pasar 490,04 M, volume 24 jam 960,5 rb). Perbedaan utamanya: Saraswanti Indoland Development Tbk. lebih besar dari sisi kapitalisasi pasar, dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 960,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | SWID | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 490,04 M |
Volume | 963,6 rb | 960,5 rb |
Lot | 9,64 rb | 9,61 rb |
Perputaran | 217,67 jt | 87,63 jt |
Harga Rata-rata | 225,89 | 91,23 |
Nilai Transaksi | 217,67 jt | 87,63 jt |
Harga Ekuilibrium Indikatif | 226 | 93 |
Volume Ekuilibrium Indikatif | 1 rb | 12 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Selengkapnya di halaman SWID →